Cryo-Cell International Inc (CCEL):企業の財務・戦略的SWOT分析

◆英語タイトル:Cryo-Cell International Inc (CCEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81683FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cryo-Cell International Inc (Cryo-Cell) operates as a cord blood bank service provider. The company offers biotechnology services, collection and preservation of umbilical cord blood stem cells for family use. It provides services such as cord blood banking, cord tissue banking, cord blood and tissue pricing, and others. Cryo-Cell offers menstrual stem cell service to capture self-renewing stem cells, and processes and cryopreserves them for cellular therapies and potential treatment of various life-threatening illness and conditions such as heart attack, Alzheimer’s disease, stroke, and spinal cord injury. Cryo-Cell is headquartered in Oldsmar, Florida, the US.

Cryo-Cell International Inc Key Recent Developments

Feb 24,2021: Cryo-Cell reports financial results for fiscal year ended November 30, 2020
Oct 15,2020: Cord blood banking leader Cryo-Cell reports fiscal third quarter 2020 financial results
Jul 10,2020: Cord Blood Banking leader Cryo-Cell reports fiscal second quarter 2020 financial results
Jun 11,2020: Cord Blood Banking Leader Cryo-Cell Enters into Patent Option Agreement with Duke University
Apr 14,2020: Cord Blood Banking leader Cryo-Cell reports fiscal first quarter 2020 financial results

This comprehensive SWOT profile of Cryo-Cell International Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cryo-Cell International Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cryo-Cell International Inc – Key Information
Cryo-Cell International Inc – Overview
Cryo-Cell International Inc – Key Employees
Cryo-Cell International Inc – Key Employee Biographies
Cryo-Cell International Inc – Key Operational Heads
Cryo-Cell International Inc – Major Products and Services
Cryo-Cell International Inc – History
Cryo-Cell International Inc – Company Statement
Cryo-Cell International Inc – Locations And Subsidiaries
Cryo-Cell International Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cryo-Cell International Inc – Business Description
Cryo-Cell International Inc – Corporate Strategy
Cryo-Cell International Inc – SWOT Analysis
SWOT Analysis – Overview
Cryo-Cell International Inc – Strengths
Cryo-Cell International Inc – Weaknesses
Cryo-Cell International Inc – Opportunities
Cryo-Cell International Inc – Threats
Cryo-Cell International Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cryo-Cell International Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cryo-Cell International Inc, Key Information
Cryo-Cell International Inc, Key Ratios
Cryo-Cell International Inc, Share Data
Cryo-Cell International Inc, Major Products and Services
Cryo-Cell International Inc, History
Cryo-Cell International Inc, Key Employees
Cryo-Cell International Inc, Key Employee Biographies
Cryo-Cell International Inc, Key Operational Heads
Cryo-Cell International Inc, Other Locations
Cryo-Cell International Inc, Subsidiaries
Cryo-Cell International Inc, Key Competitors
Cryo-Cell International Inc, SWOT Analysis
Cryo-Cell International Inc, Ratios based on current share price
Cryo-Cell International Inc, Annual Ratios
Cryo-Cell International Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cryo-Cell International Inc (CCEL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Virco Mfg Corp (VIRC):企業の財務・戦略的SWOT分析
    Summary Virco Mfg Corp (Virco) operates as a manufacturer and supplier of furniture and equipment for educational and commercial applications. The company offers chairs, desks, tables, filing cabinets, mobile cabinets, media towers, chair trucks, table trucks, bookcases, and accessories. It provides …
  • MarketSource Inc:企業の戦略的SWOT分析
    MarketSource Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Taiheiyo Cement Corporation
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Magnolia Petroleum Plc (MAGP):企業の財務・戦略的SWOT分析
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析
    Summary IDL Biotech AB (IDL Biotech) is a biotechnology company that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include b …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務分析
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mycenax Biotech Inc (4726):製薬・医療:M&Aディール及び事業提携情報
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Lockheed Martin Aeronautics Company
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • T-Mobile US Inc (TMUS):企業の財務・戦略的SWOT分析
    T-Mobile US Inc (TMUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pacific Scientific Energetic Materials Company:企業の戦略・SWOT・財務情報
    Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report Summary Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Wake Forest Innovations:製薬・医療:M&Aディール及び事業提携情報
    Summary Wake Forest Innovations (Wake Forest), a subsidiary of Wake Forest Baptist Medical Center, is a health care service provider. The center offers development and commercialization of discoveries; services; and products such as medicines and vaccines, from the Medical Center and Wake Forest Uni …
  • Liberty Media Corp (LSTZA):企業の財務・戦略的SWOT分析
    Liberty Media Corp (LSTZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Post Holdings, Inc.:企業の戦略・SWOT・財務情報
    Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Prana Biotechnology Ltd (PBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Prana Biotechnology Ltd (Prana Biotech) is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease and brain cancer, and other major age-related degenerative disorders. It is developing first-in-class therapies for the treatment of ne …
  • Texas Instruments Inc.:企業の戦略・SWOT・財務分析
    Texas Instruments Inc. - Strategy, SWOT and Corporate Finance Report Summary Texas Instruments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Shockwave Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Shockwave Medical Inc (Shockwave) is a medical device provider for the treatment of advanced cardiovascular diseases. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology which built on balloon catheter platform for the tr …
  • New York Life Insurance Company:企業のM&A・事業提携・投資動向
    New York Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New York Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • The Broad Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Ellex Medical Lasers Limited (ELX)-医療機器分野:企業M&A・提携分析
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • Marksans Pharma Ltd (MARKSANS):企業の財務・戦略的SWOT分析
    Summary Marksans Pharma Ltd (Marksans Pharma) is a pharmaceutical company that develops, manufactures and markets branded formulations and generic products. The company manufactures non-sterile liquids, ointments and powder products. It offers solid oral dosage in form of tablets, hard gelatin capsu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆